Health committee  We ran a research study where we exposed people to second-hand cannabis smoke under different conditions. One was a ventilated room environment, and one was an unventilated environment, and then within the unventilated environment we varied the potency of the cannabis that people

Health committee  For cannabis, I think it would be very wise to learn from the lessons of tobacco and alcohol regulation, very clearly. Recognizing the harms with over-consumption, recognizing the harms with advertising—it's all relevant here. It seems silly to recreate the wheel for cannabis rat

Health committee  My personal recommendation would be in favour of regulation and quality control over all products. I think that's the greater public good, rather than just allowing one version and then continuing to have black market product available where you don't know what's in it. I think t

Health committee  Again, I have not conducted any testing in Colorado. The State of Colorado does their own testing. Maybe Mr. Vigil could talk about the outcomes of the tests they have done. The testing I've done in Washington has been limited to medical cannabis dispensaries, which at the time

Health committee  In the laboratory studies we've done where we acutely dose people with different routes of administration, I think it's important to note that when we give people smoked cannabis versus edible cannabis, the magnitude of drug effects and the types of effects are identical. It's re

Health committee  Again, Colorado has their system for evaluating and testing those products and they put the ceiling on there. I'll let Mr. Vigil talk about that process, but as long as you get consistent dosing of 10 milligrams there.... We did not do our testing study in Colorado. It was conduc

Health committee  I think it's a combination of the manufacturing practices not being careful enough to put a precise amount of product in each package or in each dose, as well as difficulties with the lack of standards for testing those products.

Health committee  I think broad education needs to be disseminated regardless. In terms of THC content, you have to define a dose, and the dose depends on the individual and the reason they're using it. Right now, we're talking about non-medical use, so my presumption here is that you have people

Health committee  My guess is you're not going to roll out, at the national level, open retail sales of homegrown product. There need to be standards for manufacturing, production, and testing.

Health committee  In terms of the delay in time, typically you have the onset of effects of an edible after about 30 minutes. The peak effects happen about an hour and a half later and are sustained until about three hours after administration. The total duration of effects is about six to eight h

Health committee  The issue there is you have to test the product you're using to make the brownies, or whatever it is you're making. You have to know the potency in order to determine the dose you're putting into the product. The other thing is you have to either make each individual brownie wit

Health committee  It all depends on what the step is, don't you think? Without seeing exactly what you're talking about, it's hard for me to comment. If you're going to legalize smokable products and vaporization products first and then approach edibles, it all depends on what you ultimately do wi

Health committee  If it's sold in the store, access is the same. I don't think it's any more or less.... Access to the product is going to be determined by the way retail sales happen. If you're selling smokable products right next to edible products, it's the same. There may be some perception of

Health committee  Sure. I got the translation here. You brought up very important points. I think that testing and quality control are absolutely important in any kind of legislation. The other thing is how these products are going to be produced and provided, through what vehicle. Is it a muffi

Health committee  I probably don't have 10 minutes here, but I'll give you the brief version. I'm a human cannabinoid researcher at Johns Hopkins. I've been doing cannabis research for 17 years now. Recently I've been focused on evaluating the dose effects of cannabis, their different routes of ad